Get startedLog in
    Picture of Newbury Pharmaceuticals AB logo

    NEWBRY — Newbury Pharmaceuticals AB News Story

    0.000.00%
    se flag iconLast trade - 00:00
    Consumer DefensivesHighly SpeculativeMicro CapMomentum Trap
    All News

    Brief: Newbury Expands Its Portfolio With Two Ready To Launch Products

    Picture of Newbury Pharmaceuticals AB logoNewbury Pharmaceuticals AB
    23/11/2022 09:24
    Nov 23 (Reuters) - Newbury Pharmaceuticals AB
 NEWBRY.ST :
    * NEWBURY EXPANDS ITS PORTFOLIO WITH TWO READY TO LAUNCH
PRODUCTS
    * EXPANDS PORTFOLIO WITH DAPTOMYCIN AND LINEZOLID
    * HAVE MARKETING AUTHORIZATIONS IN SWEDEN
    * PRODUCTS WILL BE AVAILABLE FOR COMMERCIALIZATION IN 2023
    * PRODUCTS ARE SOURCED FROM NEW PARTNERS TO NEWBURY AND
BASED ON A
DISTRIBUTION AND MARKETING AGREEMENT

Source text for Eikon:  ID:nMFNc8FZ4p 
Further company coverage:  NEWBRY.ST 
 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))

    Recent news on Newbury Pharmaceuticals AB

    See all news